Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
Reduced participation means none of top five money managers fully back Climate Action 100+
Discussions about a possible strategic partnership foundered over two firms’ competing visions
As opinions shift, asset managers like BlackRock are talking more about maximising returns than about saving the world
...Pharmaceuticals groups Pfizer and Moderna, which have both faced criticism from fringe groups over their Covid-19 vaccines, also spent heavily on security for their CEOs last year....
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
Bluebell Capital Partners seeks more oversight of the money manager’s approach to sustainable investing
BlackRock chief’s annual letter also embraces ‘energy pragmatism’ amid attacks over climate stance
Admonitions about staff trading in their employer’s shares may now need to be broadened
World’s biggest money manager reports jump in first-quarter net income but net inflows miss forecasts
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
Head of world’s second-largest money manager has overseen rapid growth but faced climate criticism
A company launched in 1963 confronts challenge of adapting to the rise of anti-obesity injections
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
Large asset managers will end up on the wrong side of history, Washington envoy says
Cultural change and the potential for lower upside can drive executives away
US healthcare company is putting cash to work from spinning off its consumer health arm
...This time, the painting has been cleared for export, confirms Pierre Etienne, international director of Old Masters at Christie’s....
Reorganisation takes aim at money management industry’s poor record of innovation
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
Investors including former Treasury secretary Steven Mnuchin stand to make hundreds of millions on bailout
...“He is not a ‘master of the universe’ persona, but at the same time, don’t try to fool Bayo. He will shred you to pieces,” Chenault said....
...“We are going to have a ‘world is not flat’ moment, when asset managers are going to realise we are not prepared to help people draw down,” said Bill Meyer, CEO of Retiree Inc, a retirement planning software...
Report for 2024 on engagement priorities drops reference to global warming
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
International Edition